Hutchison China MediTech - From innovation to oncology commercialization
Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...
467 Views
Hutchison China MediTech - From innovation to oncology commercialisation
Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...
474 Views
ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Happy...
438 Views
Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind
HCM, a leading China biotech company, filed a prospectus to sell USD 110 million of ADS. We have covered the company's fundamentals for its Hong...
477 Views
Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed
HCM, a leading China biotech company, filed a prospectus to sell 8.5 million secondary ADSs. We have covered the company's fundamentals for its...
528 Views